Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ARDX Ardelyx | Assumes: Buy | 10 | 3.69 | 171% | 1 | Jun 18, 2025 | |
MLYS Mineralys Therapeuti... | Reiterates: Buy | 42 42 | 14.03 | 199.36% | 9 | Jun 17, 2025 | |
LYRA Lyra Therapeutics | Maintains: Neutral | 2 16 | 13.61 | 17.56% | 8 | Jun 10, 2025 | |
PHAT Phathom Pharmaceutic... | Reiterates: Buy | 20 20 | 9.56 | 109.21% | 10 | Jun 9, 2025 | |
AKBA Akebia Therapeutics | Assumes: Buy | 8 | 3.75 | 113.33% | 1 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 3.82 | 161.78% | 5 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | 0.79 | 153.16% | 9 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 72 | 40.34 | 78.48% | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 9 9 | n/a | n/a | 8 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 3.88 | 157.73% | 13 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 10.19 | 194.41% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 2.48 | 1109.68% | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 32 | 8.38 | 281.86% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 38 | 30.16 | 25.99% | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 0.71 | 1308.45% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 0.7 | 1614.29% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 1.02 | 684.31% | 3 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 1.95 | 2.56% | 6 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 3 | 3.76 | -20.21% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 12 2 | n/a | n/a | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 7.91 | -74.72% | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 36 36 | 4.07 | 784.52% | 18 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 18 | n/a | n/a | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 | 299.7 | -90.66% | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | n/a | n/a | 6 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Jul 18, 2022 |